US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.50

+4.580.66%

Number of Gainers:75

Number of Losers:63

Number of Flat:16

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:57.64M

Turnover:2.38B

Market Cap:479.22B

Float Cap:364.90B

Loading ...

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Core & Main's Q2 Sales Slightly Beat, Adjusted EPS Tops Estimates

Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates

MT Newswires Live

Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 Million

Core & Main Inc Fy2026 Shr View $2.89, REV View $7.68 Bln

THOMSON REUTERS

Core & Main Q2 Adjusted EPS USD 0.94 VS. Ibes Estimate USD 0.92

THOMSON REUTERS

Core & Main Q2 Net Income USD 150 Million

THOMSON REUTERS

Core & Main - Reaffirms Full-Year Fiscal 2026 Outlook Issued in March 2026

THOMSON REUTERS

Core & Main FY26 Q2 Net Income Climbs 6.4% to $150 Million; Net Sales Rise 2.5% to $2.15 Billion

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

LifeStance announces 22.25M share offering of common stock for holders

Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel

Alliant Credit Union Partners with Blend to Modernize Digital Mortgage, Home Equity Lending Platform

Coinbase Selects ION XTP Platform to Clear Kalshi Event Contracts

Ion Partners with Coinbase to Support Kalshi's Event Contracts

THOMSON REUTERS

Lifestance Health Group, - Authorizes Repurchase of 2,000,000 Shares from Underwriter

THOMSON REUTERS

Lifestance Health Group, - Announces Secondary Offering of 22,250,000 Shares by Selling Stockholders

THOMSON REUTERS

Lifestance Health Group Announces Launch of Secondary Public Offering

THOMSON REUTERS

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

LifeStance Health Group Announces Launch of Secondary Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK4539/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.495,"timestamp":1789137420142,"preClose":688.91504,"halted":0,"volume":57638387,"delay":0,"changeRate":0.006648,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":4.579956,"latestTime":"09-11 10:37:03 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":2380002448.068525,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322493,"peRate":139.789284,"turnoverRate":0.004543,"increases":75,"decrements":65,"flats":10,"marketCap":479217421545.25,"floatMarketCap":364899638796.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322493","latestPrice":693.495,"volume":57638385,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.00454,"peRate":139.789284,"marketCap":479386797289.25,"floatMarketCap":365045488620.125,"timestamp":1789137420099,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":75,"down":63,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666358001","title":"Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2666358001","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666358001?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:45","pubTimestamp":1788954300,"startTime":"0","endTime":"0","summary":"- Independent Safety Monitoring Committee recommends advancement to Cohort 2 following blinded review of Cohort 1 safety and tolerability data – - Pharmacokinetic observations at the lowest dose evalu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358540/0/en/serina-therapeutics-reports-cohort-1-observations-from-ser-252-registrational-study-in-advanced-parkinson-s-disease-and-advances-to-cohort-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2931357623.SGD","LU0274383776.USD","BK4007","BK4157","IE00B66KJ199.SGD","IE00B7SZL793.SGD","LENZ","SMC","BK4144","AEIS","LU1815336091.USD","LU0757428866.USD","IE0031619046.USD","BK4539","LU2089985449.USD","IE00B19Z4B17.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666989580","title":"Core & Main's Q2 Sales Slightly Beat, Adjusted EPS Tops Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666989580","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666989580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:39","pubTimestamp":1788953967,"startTime":"0","endTime":"0","summary":"Core & Main's Q2 sales slightly beat, adjusted EPS tops estimatesOverviewUS specialty distributor's fiscal Q2 net sales grew 2.5%, slightly beating analyst expectationsAdjusted EPS for fiscal Q2 beat ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N4510F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2125910179.SGD","BK4102","CNM","LU2413665964.HKD","LU1721427968.SGD","IE0009354923.USD","LU1620156213.USD","LU1620156130.USD","LU2125910336.SGD","BK4104","LU1596574779.USD","EVI","UNFI","LU1165135440.EUR","LU1923621640.USD","LU2229751404.USD","LU2413666004.HKD","LU2089279066.USD","LU1543694498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666958050","title":"Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666958050","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666958050?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:33","pubTimestamp":1788953580,"startTime":"0","endTime":"0","summary":"Schrodinger (SDGR), along with New Enterprise Associates and RA Capital Management, established a new biotechnology company named Tectora Therapeutics, according to a Wednesday statement.Concurrently,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4588","LENZ","EFSC","SDGR","BK4167","BK4139","BK4585","BK4211","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666258054","title":"Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258054","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258054?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:32","pubTimestamp":1788953520,"startTime":"0","endTime":"0","summary":"BRIEF-Core & Main Q2 Sales USD 2,145 Million Vs. IBES Estimate USD 2,136 MillionSep 09 (Reuters) - Core & Main Q2 adjusted EBITDA USD 274 million vs. IBES estimate USD 280.7 million.Q2 adjusted EPS USD 0.94 vs. IBES estimate USD 0.92Q2 EPS USD 0.77Q2 net income USD 150 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413665964.HKD","BK4104","LU2125910179.SGD","LU1620156130.USD","BK4539","LU1543694498.USD","LU2125910336.SGD","LU2229751404.USD","LU1165135440.EUR","LU2089279066.USD","LU2413666004.HKD","LU1923621640.USD","LU1721427968.SGD","LU1596574779.USD","LU1620156213.USD","IE0009354923.USD","CNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580567","title":"Core & Main Inc Fy2026 Shr View $2.89, REV View $7.68 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580567?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910336.SGD","BK4104","LU2413665964.HKD","LU2413666004.HKD","LU1923621640.USD","CNM","IE0009354923.USD","LU2089279066.USD","LU2229751404.USD","LU2125910179.SGD","LU1596574779.USD","LU1721427968.SGD","BK4539","LU1165135440.EUR","LU1620156130.USD","LU1620156213.USD","LU1543694498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580325","title":"Core & Main Q2 Adjusted EPS USD 0.94 VS. Ibes Estimate USD 0.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580325","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580325?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2413665964.HKD","BK4539","BK4104","LU1620156130.USD","LU2125910179.SGD","LU1923621640.USD","LU2125910336.SGD","CNM","LU1543694498.USD","LU1596574779.USD","LU2413666004.HKD","LU2229751404.USD","IE0009354923.USD","LU1721427968.SGD","LU1165135440.EUR","LU1620156213.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580320","title":"Core & Main Q2 Net Income USD 150 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580320?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910336.SGD","LU1596574779.USD","IE0009354923.USD","BK4539","LU1620156213.USD","LU2089279066.USD","BK4104","LU2229751404.USD","LU1543694498.USD","LU2125910179.SGD","LU2413666004.HKD","LU1165135440.EUR","CNM","LU1923621640.USD","LU1721427968.SGD","LU1620156130.USD","LU2413665964.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309580","title":"Core & Main - Reaffirms Full-Year Fiscal 2026 Outlook Issued in March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:31","pubTimestamp":1788953461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXMXWSN4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2413666004.HKD","LU2089279066.USD","LU1596574779.USD","IE0009354923.USD","BK4104","LU1620156130.USD","LU1620156213.USD","LU2125910179.SGD","LU2229751404.USD","BK4539","LU1165135440.EUR","LU2125910336.SGD","LU1543694498.USD","LU1923621640.USD","CNM","LU2413665964.HKD","LU1721427968.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580537","title":"Core & Main FY26 Q2 Net Income Climbs 6.4% to $150 Million; Net Sales Rise 2.5% to $2.15 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580537","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580537?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:30","pubTimestamp":1788953456,"startTime":"0","endTime":"0","summary":"Core & Main FY26 Q2 net income climbs 6.4% to $150 million; net sales rise 2.5% to $2.15 billionCore & Main posted fiscal 2026 Q2 net sales up 2.5% to $2.15 billion versus the prior-year quarter.GAAP ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6TL72h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","LU1620156130.USD","LU1620156213.USD","LU1721427968.SGD","LU1923621640.USD","LU2413665964.HKD","BK4539","CNM","LU2413666004.HKD","BK4104","LU2125910179.SGD","IE0009354923.USD","LU2125910336.SGD","LU1543694498.USD","LU1596574779.USD","LU2229751404.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666800915","title":"Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202","url":"https://stock-news.laohu8.com/highlight/detail?id=2666800915","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666800915?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:30","pubTimestamp":1788953400,"startTime":"0","endTime":"0","summary":"CT-202 is a Nectin-4 x CD3 T cell engaging bispecific antibody Phase 1 trial is evaluating CT-202 as a monotherapy treatment in patients with urothelial, colorectal, and triple-negative breast cancers","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358524/0/en/context-therapeutics-announces-first-patient-dosed-in-phase-1-trial-of-ct-202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666872955","title":"LifeStance announces 22.25M share offering of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666872955","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666872955?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952541,"startTime":"0","endTime":"0","summary":"LifeStance (LFST) Health Group announced that pursuant to a shelf registration statement filed with the SEC, certain stockholders of the company in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifestance-announces-22-25m-share-offering-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifestance-announces-22-25m-share-offering-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4535","FMED","BK4539","LFST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666796587","title":"Autolus Therapeutics granted RMAT designation for obecabtagene autoleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2666796587","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666796587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952531,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics (AUTL) announced that the FDA has granted regenerative medicine advanced therapy, or RMAT, designation to obecabtagene autoleu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-granted-rmat-designation-for-obecabtagene-autoleucel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LENZ","AUTL","LABU","BK4139","BK4539","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587627","title":"Alliant Credit Union Partners with Blend to Modernize Digital Mortgage, Home Equity Lending Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587627","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587627?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:08","pubTimestamp":1788952120,"startTime":"0","endTime":"0","summary":"Alliant Credit Union partners with Blend to modernize digital mortgage, home equity lending platformAlliant Credit Union partnered with Blend Labs on a modernized digital mortgage, home equity lending","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL7yr5Xq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLND","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587350","title":"Coinbase Selects ION XTP Platform to Clear Kalshi Event Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587350","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587350?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:02","pubTimestamp":1788951729,"startTime":"0","endTime":"0","summary":"Coinbase selects ION XTP platform to clear Kalshi event contractsCoinbase selected ION’s XTP for Event Contracts to support clearing for Kalshi’s event contracts.Platform targets real-time creation, r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL8qKG7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICOI","CONX","CRPT","IACB.U","BK4516","BK4539","BK4112","DAPP","LU2360107671.USD","COIX","CONL","BKCH","LU1861559042.SGD","09311","FINX","COIG","BK4585","CONY","BK4595","COIO","COIA","BK4596","09711","BK4600","07311","CONI","COYY","BK4588","COIW","COII","FDIG","LU1861220207.SGD","BK4554","IBLC","07711","FIAT","BK4535","BITQ","LU1861217088.USD","BLCK","LU1861558580.USD","COIN","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582027","title":"Ion Partners with Coinbase to Support Kalshi's Event Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582027?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA1RTY9V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FINX","CONI","BK4600","BITQ","ICOI","BK4596","IBLC","CONL","COIG","LU1861558580.USD","CONY","BKCH","LU1861217088.USD","09711","BK4551","BLCK","COIX","07311","COIO","BK4595","BK4585","07711","COYY","CRPT","LU1861559042.SGD","COIW","CONX","COIA","FDIG","BK4112","BK4539","BK4588","BK4554","BK4535","FIAT","DAPP","BK4516","LU1861220207.SGD","09311","COII","LU2360107671.USD","COIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587895","title":"Lifestance Health Group, - Authorizes Repurchase of 2,000,000 Shares from Underwriter","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587895?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA9DDKRN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","FMED","LFST","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558204","title":"Lifestance Health Group, - Announces Secondary Offering of 22,250,000 Shares by Selling Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558204","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558204?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA9DDKRN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4539","FMED","LFST","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666017582","title":"Lifestance Health Group Announces Launch of Secondary Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666017582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666017582?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUA9DDKRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FMED","BK4539","BK4196","LFST","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666941587","title":"Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666941587","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666941587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Enrollment in LUMINA, the pivotal Phase 2 study of obe-cel in refractory lupus nephritis, is ongoingLONDON and GAITHERSBURG, Md., Sept.  09, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358486/0/en/autolus-therapeutics-announces-fda-rmat-designation-granted-to-obe-cel-for-the-treatment-of-systemic-lupus-erythematosus-and-lupus-nephritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4110","BK4139","LABU","BK4588","BK4007","SLE","BK4585","BK4077","BK4539","ACR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587926","title":"LifeStance Health Group Announces Launch of Secondary Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587926","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587926?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"SCOTTSDALE, Ariz., Sept.  09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outp","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358499/0/en/lifestance-health-group-announces-launch-of-secondary-public-offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK4535","BK4588","LFST","VHT","FMED","BK4539","BK4196","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":11,"totalSize":896,"code":"91000000","status":"200"}]}}